KC
Kalyani Chinthala
About Kalyani Chinthala
Data last updated:
Kalyani Chinthala is a Director at Biowin Life Sciences Private Limited (since 2026) and Designated Partner at Basilwin Pharmaceuticals Llp (since 2024). The companies operate in Pharma.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Biowin Life Sciences Private Limited U47721TS2026PTC209309 | Director | 07 Jan 2026 | 2026 | Active | |
| Basilwin Pharmaceuticals Llp ACF-1368 | Designated Partner | 25 Jan 2024 | 2024 | Active |
Board colleagues of Kalyani Chinthala
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sreeram Gutipalli | 10268883 | Biowin Life Sciences Private Limited | Director |
| Shyamala Mekala | 10479960 | Basilwin Pharmaceuticals Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kalyani Chinthala
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kalyani Chinthala
Kalyani Chinthala currently holds 2 directorships: Biowin Life Sciences Private Limited (Director, since 07 Jan 2026); Basilwin Pharmaceuticals Llp (Designated Partner, since 25 Jan 2024).
Kalyani Chinthala was first appointed on 25 Jan 2024 as Designated Partner at Basilwin Pharmaceuticals Llp. The most recent appointment on record is 07 Jan 2026 at Biowin Life Sciences Private Limited.
The current boards of Kalyani Chinthala's companies include Sreeram Gutipalli (Biowin Life Sciences Private Limited), Shyamala Mekala (Basilwin Pharmaceuticals Llp).